ストックスクリーナーアプリを入手
1.49
0.00%
0.00
前日終値:
$1.49
開ける：
$1.49
24時間の取引高:
784.92K
Relative Volume:
0.40
時価総額：
$273.21M
収益：
$137.74M
当期純損益:
$-27.97M
株価収益率:
-9.3125
EPS:
-0.16
ネットキャッシュフロー:
$-9.61M
1週間 パフォーマンス:
+7.19%
1か月 パフォーマンス:
+7.97%
6か月 パフォーマンス:
-26.24%
1年 パフォーマンス:
-5.10%
1日の値動き範囲:
$1.46
$1.52
1週間の範囲:
$1.40
$1.57
52週間の値動き範囲:
$0.9999
$2.68
Heron Therapeutics Inc Stock (HRTX) Company Profile
名前
Heron Therapeutics Inc
セクター
電話
(858) 251-4400
住所
4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA
HRTX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
HRTX
Heron Therapeutics Inc
|
1.49 | 273.21M | 137.74M | -27.97M | -9.61M | -0.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
Heron Therapeutics Inc Stock (HRTX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-06-09 | 開始されました | H.C. Wainwright | Buy |
| 2024-06-13 | 開始されました | Rodman & Renshaw | Buy |
| 2024-04-23 | 開始されました | CapitalOne | Overweight |
| 2024-03-13 | 繰り返されました | Needham | Buy |
| 2020-05-27 | 開始されました | Guggenheim | Buy |
| 2020-02-20 | 繰り返されました | Needham | Buy |
| 2019-01-16 | 繰り返されました | Needham | Buy |
| 2018-04-05 | 開始されました | Evercore ISI | Outperform |
| 2018-03-19 | 繰り返されました | Mizuho | Buy |
| 2018-03-01 | 繰り返されました | Needham | Buy |
| 2018-01-03 | 開始されました | Leerink Partners | Outperform |
| 2017-09-27 | 開始されました | Northland Capital | Outperform |
| 2017-02-27 | 開始されました | Needham | Buy |
| 2016-10-26 | 開始されました | Aegis Capital | Buy |
| 2016-09-06 | 再開されました | Lake Street | Buy |
| 2016-05-03 | 開始されました | Cantor Fitzgerald | Buy |
| 2015-12-10 | 開始されました | Lake Street | Buy |
| 2015-09-23 | 繰り返されました | Leerink Partners | Outperform |
| 2015-09-02 | 開始されました | BofA/Merrill | Buy |
| 2015-08-03 | 繰り返されました | Brean Capital | Buy |
| 2015-06-30 | 繰り返されました | JMP Securities | Mkt Outperform |
| 2015-06-19 | 繰り返されました | Leerink Partners | Outperform |
| 2014-08-07 | 開始されました | Noble Financial | Buy |
すべてを表示
Heron Therapeutics Inc (HRTX) 最新ニュース
Heron Therapeutics, Inc. (NASDAQ:HRTX) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Quarterly Trades: Can Heron Therapeutics Inc expand into new marketsStock Surge & Verified Momentum Stock Ideas - baoquankhu1.vn
VIX Spike: Is Heron Therapeutics Inc affected by consumer sentimentEarnings Growth Report & Fast Entry Momentum Alerts - baoquankhu1.vn
Aug Drivers: Is Heron Therapeutics Inc stock vulnerable to regulatory risksEntry Point & Smart Money Movement Alerts - Bộ Nội Vụ
Heron rises as preliminary revenue figures exceed estimates - MSN
Returns Recap: Does Heron Therapeutics Inc stock trade at a discount to peers - Bộ Nội Vụ
Great week for Heron Therapeutics, Inc. (NASDAQ:HRTX) institutional investors after losing 10% over the previous year - simplywall.st
Heron Therapeutics’ Q4 Earnings Beat Forecasts, Boosted by Acute Care Success - timothysykes.com
HC Wainwright Reaffirms Buy Rating for Heron Therapeutics (NASDAQ:HRTX) - Defense World
Heron Therapeutics’ Revenue Soars Beyond Expectations in Q4 2025 - StocksToTrade
Heron Therapeutics Revenue Exceeds Estimates with Strong Acute Care Performance - StocksToTrade
Heron Therapeutics Surpasses Revenue Expectations with Significant Growth - timothysykes.com
Heron Therapeutics sees Q4 revenue $40.5M, consensus $39.83M - Yahoo Finance
How supply chain issues affect Heron Therapeutics Inc. stockMarket Sentiment Review & Real-Time Stock Movement Alerts - Улправда
How Heron Therapeutics Inc. stock reacts to global recession fears2025 Price Momentum & Daily Profit Focused Stock Screening - Улправда
Can Heron Therapeutics Inc. stock surprise with earnings upsideCEO Change & Real-Time Buy Signal Alerts - Улправда
Heron Therapeutics Expands Strategic Vision Amid Market Fluctuations - StocksToTrade
Heron Therapeutics Reports Strong Preliminary Q4 2025 Revenue - TipRanks
HRTX: HC Wainwright & Co. Reiterates Buy Rating with $6 Price Ta - GuruFocus
Heron Therapeutics' (HRTX) "Buy" Rating Reiterated at HC Wainwright - MarketBeat
Heron Therapeutics stock soars after strong Q4 revenue growth By Investing.com - Investing.com Canada
Heron Therapeutics announces preliminary, unaudited Q4 results - marketscreener.com
Heron Therapeutics Reports Preliminary Fourth Quarter and Full-Year 2025 Financial Results - Quiver Quantitative
Heron Therapeutics Announces Preliminary, Unaudited Q4 and - GlobeNewswire
Will Heron Therapeutics Inc. stock gain from strong economy2025 Key Lessons & Long-Term Growth Stock Strategies - Улправда
What technical signals suggest for Heron Therapeutics Inc. stock2025 Retail Activity & Daily Profit Maximizing Tips - Улправда
Does Heron Therapeutics Inc. stock trade at a discount to peers2025 Bull vs Bear & High Yield Stock Recommendations - Улправда
How analysts rate Heron Therapeutics Inc. stock todayWeekly Gains Summary & Verified Momentum Stock Alerts - Улправда
Will Heron Therapeutics Inc. stock maintain dividend yield2025 Volatility Report & Long Hold Capital Preservation Tips - Улправда
Can Heron Therapeutics Inc. stock sustain market leadershipIndustrial Stocks Review & High Profit Growth Stocks - ulpravda.ru
Will Heron Therapeutics Inc. stock outperform tech sector in 20252026 world cup usa national team group stage star players high defensive line tactical prediction insights - Улправда
Is Heron Therapeutics Inc AXD2 a good long term investmentConsumer Goods Stocks & Small Capital Gains - earlytimes.in
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Exit Recap: Does Heron Therapeutics Inc stock trade at a discount to peers2025 Market WrapUp & Verified Momentum Watchlists - Bộ Nội Vụ
What analysts say about Heron Therapeutics Inc AXD2 stockContrarian Investment Ideas & High Return Investment Growth - earlytimes.in
Heron Therapeutics, Inc. (NASDAQ:HRTX) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Investor Mood: Will Heron Therapeutics Inc stock outperform tech sector in 2025Bear Alert & Long Hold Capital Preservation Tips - moha.gov.vn
Is Heron Therapeutics Inc. stock attractive for income investorsJuly 2025 Highlights & Capital Protection Trading Alerts - Улправда
Is Heron Therapeutics Inc. stock cheap at current valuationJuly 2025 Drop Watch & Safe Investment Capital Preservation Plans - DonanımHaber
Can Heron Therapeutics Inc. stock sustain revenue growthJuly 2025 Review & Growth Focused Stock Reports - Улправда
Is Heron Therapeutics Inc. stock gaining market shareInflation Watch & Community Consensus Trade Alerts - Улправда
Heron Therapeutics Earnings Notes - Trefis
Is Heron Therapeutics Stock Built to Withstand More Downside? - Trefis
Congress Park Capital LLC Acquires 621,908 Shares of Heron Therapeutics, Inc. $HRTX - Defense World
Heron Therapeutics, Inc. (NASDAQ:HRTX) Stock Catapults 27% Though Its Price And Business Still Lag The Industry - simplywall.st
Heron Therapeutics, Inc. (NASDAQ:HRTX) is favoured by institutional owners who hold 57% of the company - Yahoo Finance
Heron Therapeutics Appoints Thomas Cusack to Board - MSN
Heron Therapeutics Reports Strong Q3 2025 Revenue Growth - MSN
Heron Therapeutics Inc (HRTX) 財務データ
収益
当期純利益
現金流量
EPS
Heron Therapeutics Inc (HRTX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Morgan Adam | Director |
Aug 08 '25 |
Buy |
1.50 |
1,766,546 |
2,649,819 |
8,753,290 |
4.73%
0.92%
大文字化:
|
ボリューム (24 時間):